Advisory Commission on Childhood Vaccines; Notice of Meeting, 47657-47658 [2014-19201]

Download as PDF 47657 Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden on historic evidence of patients’ unavailability due to frequent transitions in health status, as well as between home and the hospital for initial treatment and care for complications. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to Number of respondents Form name Number of responses per respondent hours estimated for this Information Collection Request are summarized in the table below. The total respondent burden for the satisfaction survey is estimated to be 105 hours. We expect a total of 420 respondents (33% response rate) to complete the Be The Match® Patient Services Survey. Total Estimated Annualized burden hours: Total responses Average burden per response (in hours) Total burden hours Be The Match® Patient Services Survey ............................ 420 1 420 0.25 105 Total .............................................................................. 420 1 420 0.25 105 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Dated: August 8, 2014. Jackie Painter, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2014–19198 Filed 8–13–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines; Notice of Meeting tkelley on DSK3SPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: September 04, 2014, 1:00 p.m. to 5:35 p.m. EDT; September 05, 2014, 9:00 a.m. to 1:45 p.m. EDT. Place: Parklawn Building (and via audio conference call and Adobe Connect), Conference Room 10–65, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Thursday, September 04, 2014, 1:00 p.m. to 5:35 p.m. EDT and Friday, September 05, 2014, 9:00 a.m. to 1:45 p.m. EDT. The public can join the meeting by: VerDate Mar<15>2010 16:42 Aug 13, 2014 Jkt 232001 1. (In Person) Persons interested in attending the meeting in person are encouraged to submit a written notification to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857 or email: aherzog@hrsa.gov. Since this meeting is held in a federal government building, attendees will need to go through a security check to enter the building and participate in the meeting. This written notification is encouraged so that a list of attendees can be provided to make entry through security quicker. Persons may attend in person without providing written notification, but their entry into the building may be delayed due to security checks and the requirement to be escorted to the meeting by a federal government employee. To request an escort to the meeting after entering the building, call Mario Lombre at 301–443–3196. The meeting will be held at the Parklawn Building, Conference Room 10–65, 5600 Fishers Lane, Rockville, Maryland 20857. 2. (Audio Portion) Calling the conference phone number, 877–917–4913, and providing the following information: Leaders Name: Dr. A. Melissa Houston. Password: ACCV. 3. (Visual Portion) Connecting to the ACCV Adobe Connect Pro Meeting using the following URL: https:// hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/ common/help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_ overview. 4. Call (301) 443–6634 or send an email to aherzog@hrsa.gov if you are having trouble connecting to the meeting site. Agenda: The agenda items for the September meeting will include, but are not PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 limited to: Updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration); Clarification on Proposed Changes to the Vaccine Injury Table; VICP Outreach Plan; Report from the ACCV Process Workgroup; Review of Vaccine Information Statements; Presentation on Pneumococcal Polysaccharide (Pneumovax 23) and Zoster (Shingles) Vaccine Safety Review; and a Discussion of Proposed Revisions to VAERS Form (2.0). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http://www.hrsa.gov/ vaccinecompensation/accv.htm) prior to the meeting. Agenda items are subject to change as priorities dictate. Public Comment: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857 or email: aherzog@ hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by email, mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits. For further information contact: Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, E:\FR\FM\14AUN1.SGM 14AUN1 47658 Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443– 6634 or email: aherzog@hrsa.gov. Dated: August 6, 2014. Jackie Painter, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2014–19201 Filed 8–13–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting tkelley on DSK3SPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Council on Blood Stem Cell Transplantation. Date and Time: September 15, 2014, 8:00 a.m. to 4:30 p.m. (Eastern Standard Time). Place: Fishers Lane Conference Center, Terrace Level, 5635 Fishers Lane, Rockville, MD 20852. Status: The meeting will be open to the public. Purpose: Pursuant to Public Law 109–129, 42 U.S.C. 274k (section 379 of the Public Health Service Act, as amended), the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) advises the Secretary of the Department of Health and Human Services and the Administrator, Health Resources and Services Administration, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program (Program) and the National Cord Blood Inventory Program. Agenda: The Council will hear reports from ACBSCT Work Groups including: Realizing the Potential of Cord Blood; Access to Transplantation; and Advancing Hematopoietic Stem Cell Transplantation for Hemoglobinopathies. The Council also will hear presentations and discussions on topics including: Financial Issues Related to Stem Cell Transplantation and Quality of Care. Agenda items are subject to changes as priorities indicate. After Council discussions, members of the public will have an opportunity to provide comments. Because of the Council’s full agenda and the time frame in which to cover the agenda topics, public comment will be limited. All public comments will be included in the record of the ACBSCT meeting. Meeting summary notes will be posted on the HRSA’s Program Web site at http://bloodcell.transplant.hrsa.gov/ABOUT/ Advisory_Council/index.html. Those participating in this meeting can register and view the draft meeting agenda by visiting https://www.blsmeetings.net/acbsct. The deadline to register for this meeting is Friday, September 12, 2014. For all logistical questions and concerns, please contact Anita Allen, Seamon Corporation, by calling (301) VerDate Mar<15>2010 17:56 Aug 13, 2014 Jkt 232001 658–3442 or by sending an email to aallen@ seamoncorporation.com. Public Comment: It is preferred that persons interested in providing an oral presentation submit a written request, along with a copy of their presentation to: Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, Room 17W65, 5600 Fishers Lane, Rockville, Maryland 20857 or email at pstroup@ hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may request this at the time of the public comment period. Public participation and ability to comment will be limited to time as it permits. For Further Information Contact: Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 17W63, Rockville, Maryland 20857; telephone (301) 443–1127. Dated: August 8, 2014. Jackie Painter, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2014–19218 Filed 8–13–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis, and Sexually Transmitted Disease (STD) Prevention and Treatment Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: The Health Resources and Services Administration (HRSA) is requesting nominations to fill three vacancies on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT). DATES: Nominations should be submitted electronically or in writing, and must be postmarked by August 30, 2014. ADDRESSES: All nominations should be submitted by email to: Shelley B. Gordon, Public Health Analyst, at SUMMARY: PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 sgordon@hrsa.gov or mailed to Shelley B. Gordon, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Room 7C–26, Rockville, Maryland 20857, no later than September 15, 2014. FOR FURTHER INFORMATION CONTACT: Shelley B. Gordon, Public Health Analyst, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Room 7C–26, Rockville, Maryland 20857, sgordon@hrsa.gov, 301–443–9684. SUPPLEMENTARY INFORMATION: The CHACHSPT is governed by the Federal Advisory Committee Act, Public Law 92–643 (5 U.S.C. App. 2), as amended, which sets forth the standards for the formation and use of advisory committees. The CHACHSPT consists of 18 experts knowledgeable in the fields of public health, epidemiology, laboratory practices, immunology, infectious diseases, drug abuse, behavioral science, health education, healthcare delivery, state health programs, clinical care, preventive health, medical education, health services and clinical research, and healthcare financing, who are selected by the Secretary of the U.S. Department of Health and Human Services (HHS). The CHACHSPT provides advice to the Secretary, HHS; the Director, CDC; and the Administrator, HRSA, on objectives, strategies, policies, and priorities for HIV, viral hepatitis, and STD prevention and treatment efforts including surveillance of HIV infection, AIDS, viral hepatitis, other STDs, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS, viral hepatitis, and other STDs; identification of policy issues related to HIV/viral hepatitis/STD professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS, viral hepatitis, and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to the agencies in their development of responses to emerging health needs related to HIV, viral hepatitis, and other STDs. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the Committee’s objectives. Nominees will be selected from experts having experience in HIV/AIDS, viral hepatitis, and STDs prevention and control. Experts in the disciplines of epidemiology, laboratory practice, E:\FR\FM\14AUN1.SGM 14AUN1

Agencies

[Federal Register Volume 79, Number 157 (Thursday, August 14, 2014)]
[Notices]
[Pages 47657-47658]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-19201]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: September 04, 2014, 1:00 p.m. to 5:35 p.m. EDT; 
September 05, 2014, 9:00 a.m. to 1:45 p.m. EDT.
    Place: Parklawn Building (and via audio conference call and 
Adobe Connect), Conference Room 10-65, 5600 Fishers Lane, Rockville, 
MD 20857.
    The ACCV will meet on Thursday, September 04, 2014, 1:00 p.m. to 
5:35 p.m. EDT and Friday, September 05, 2014, 9:00 a.m. to 1:45 p.m. 
EDT. The public can join the meeting by:
    1. (In Person) Persons interested in attending the meeting in 
person are encouraged to submit a written notification to: Annie 
Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and 
Services Administration (HRSA), Room 11C-26, 5600 Fishers Lane, 
Rockville, Maryland 20857 or email: aherzog@hrsa.gov. Since this 
meeting is held in a federal government building, attendees will 
need to go through a security check to enter the building and 
participate in the meeting. This written notification is encouraged 
so that a list of attendees can be provided to make entry through 
security quicker. Persons may attend in person without providing 
written notification, but their entry into the building may be 
delayed due to security checks and the requirement to be escorted to 
the meeting by a federal government employee. To request an escort 
to the meeting after entering the building, call Mario Lombre at 
301-443-3196. The meeting will be held at the Parklawn Building, 
Conference Room 10-65, 5600 Fishers Lane, Rockville, Maryland 20857.
    2. (Audio Portion) Calling the conference phone number, 877-917-
4913, and providing the following information:

Leaders Name: Dr. A. Melissa Houston.
Password: ACCV.

    3. (Visual Portion) Connecting to the ACCV Adobe Connect Pro 
Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work 
directly, and enter as a guest). Participants should call and 
connect 15 minutes prior to the meeting in order for logistics to be 
set up. If you have never attended an Adobe Connect meeting, please 
test your connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm 
and get a quick overview by following URL: http://www.adobe.com/go/connectpro_overview.
    4. Call (301) 443-6634 or send an email to aherzog@hrsa.gov if 
you are having trouble connecting to the meeting site.
    Agenda: The agenda items for the September meeting will include, 
but are not limited to: Updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health), and Center for Biologics, 
Evaluation and Research (Food and Drug Administration); 
Clarification on Proposed Changes to the Vaccine Injury Table; VICP 
Outreach Plan; Report from the ACCV Process Workgroup; Review of 
Vaccine Information Statements; Presentation on Pneumococcal 
Polysaccharide (Pneumovax 23) and Zoster (Shingles) Vaccine Safety 
Review; and a Discussion of Proposed Revisions to VAERS Form (2.0). 
A draft agenda and additional meeting materials will be posted on 
the ACCV Web site (http://www.hrsa.gov/vaccinecompensation/accv.htm) 
prior to the meeting. Agenda items are subject to change as 
priorities dictate.
    Public Comment: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau 
(HSB), Health Resources and Services Administration (HRSA), Room 
11C-26, 5600 Fishers Lane, Rockville, MD 20857 or email: 
aherzog@hrsa.gov. Requests should contain the name, address, 
telephone number, email address, and any business or professional 
affiliation of the person desiring to make an oral presentation. 
Groups having similar interests are requested to combine their 
comments and present them through a single representative. The 
allocation of time may be adjusted to accommodate the level of 
expressed interest. DVIC will notify each presenter by email, mail 
or telephone of their assigned presentation time. Persons who do not 
file an advance request for a presentation, but desire to make an 
oral statement, may announce it at the time of the public comment 
period. Public participation and ability to comment will be limited 
to space and time as it permits.
    For further information contact: Anyone requiring information 
regarding the ACCV should contact Annie Herzog, DVIC, HSB,

[[Page 47658]]

HRSA, Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone 
(301) 443-6634 or email: aherzog@hrsa.gov.

    Dated: August 6, 2014.
Jackie Painter,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2014-19201 Filed 8-13-14; 8:45 am]
BILLING CODE 4165-15-P